Am J Transplant, Volume 19, Suppl 3 Archives - Page 146 of 214 - ATC Abstracts

2019 American Transplant Congress
Apixaban Therapy Is Safe And Effective In Most Organ Transplant Populations
A. Brown, S. Palkimas, W. Ally
University of Virginia Health System, Charlottesville, VA
*Purpose: The bleed rates from the apixaban pivotal trial were 12.1% for non-major and 3.8% major bleeds. However outcomes in transplant recipients are less defined,…
2019 American Transplant Congress
Identifying the Proverbial “Needle in the Arm” with Natural Language Processing
G. R. Vece, J. Foutz, A. Placona
Department of Research, United Network for Organ Sharing, Richmond, VA
*Purpose: Donors with a history of IVDU are associated with increased disease transmission risk; However, OPTN forms only request broad historical details relating to donor…
2019 American Transplant Congress
Impact of DAA Treatment on Graft Fibrosis in HCV Positive Liver Transplantation
J. Wellington¹, A. Ma², S. Kottilil³, J. Husson³, E. Wilson³, D. Bruno⁴
¹Gastroenterology & Hepatology, University of Maryland, Baltimore, MD, ²Internal Medicine, University of Maryland, Baltimore, MD, ³Institute of Human Virology, Division of Clinical Care and Research, University of Maryland, Baltimore, MD, ⁴Transplant Surgery, University of Maryland, Baltimore, MD
*Purpose: Liver transplantation, LT, for HCV-related disease has the lowest five-year graft survival of all LT recipients, primarily due to accelerated fibrosis from unrestrained HCV…
2019 American Transplant Congress
Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation
S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen
Organ Transplant Center, the First Affiliated Hospital of SYSU, Guangzhou, China
*Purpose: Ischemia-reperfusion injury (IRI) is a major challenge in liver resection and liver transplantation surgery. Hepatic IRI can seriously impair liver function and even cause…
2019 American Transplant Congress
Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients
E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside
Section of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery advanced practice providers (APPs) roles and responsibilities vary widely between different transplant centers. In an effort to standardize care for the pancreas…
2019 American Transplant Congress
The Need for Diabetic Medications after Pancreas Transplantation
A. Bhansali, O. El Shamy, M. Menon, R. Shapiro, V. Delaney, G. De Boccardo
Mount Sinai Hospital, New York, NY
*Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…
2019 American Transplant Congress
Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)
T. Janaudis-Ferreira¹, S. Mathur², R. Deliva³, N. Howes⁴, C. Patterson⁵, A. Räkel⁶, S. So⁵, L. Wickerson⁷, M. White⁶, Y. Avitzur⁵, O. Johnston⁸, N. Heywood⁹, S. Singh⁷, S. Holdsworth¹⁰
¹School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada, ²University of Toronto, Toronto, ON, Canada, ³The Hospital for Sick Children, Toronto, ON, Canada, ⁴London Health Sciences Centre, London, ON, Canada, ⁵The Hospital For Sick Children, Toronto, ON, Canada, ⁶University of Montreal Hospital Centre, Montreal, QC, Canada, ⁷University Health Network, Toronto, ON, Canada, ⁸Vancouver General Hospital, Vancouver, BC, Canada, ⁹McGill University Health Centre, Montreal, QC, Canada, ¹⁰Canadian Donation and Transplantation Research Program, Edmonton, AB, Canada
*Purpose: Exercise training has been shown to be beneficial across several chronic disease groups that may lead to solid organ transplantation (SOT), and across organ…
2019 American Transplant Congress
A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients
J. Langlee, L. Lees, A. Saha, D. Helfer, M. Waldram, A. Love, F. Rivera, A. Massie, D. Segev, D. Brennan, M. Henderson
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The leading predictor of rejection, de novo DSA, graft loss, and death among adult kidney transplant (KT) recipients is immunosuppressive medication nonadherence. An estimated…
2019 American Transplant Congress
Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis
A. Chewcharat¹, C. Thongprayoon², B. Boonpheng³, A. Torres-Ortiz⁴, M. A Mao², N. J Khoury⁵, W. Cheungpasitporn⁴
¹Harvard T.H. Chan, Boston, MA, ²Mayo Clinic, Rochester, MN, ³East Tennessee State University, Johnson City, TN, ⁴University of Mississippi Medical Center, Jackson, MS, ⁵Henry Ford Hospital, Detroit, MI
*Purpose: The incidence and mortality of renal cell carcinoma (RCC) after kidney transplantation (KTx) remain unclear. This study's aims were 1) to investigate the pooled…
2019 American Transplant Congress
Paradoxical Liver Simulated Allocation Model (LSAM) Projections for Changes to Waitlist Mortality under Acuity Circle Distribution Model
R. Lynch¹, K. Ross¹, S. Karp²
¹Emory, Atlanta, GA, ²Vanderbilt, Nashville, TN
*Purpose: In December 2018, the United Network for Organ Sharing (UNOS) board voted to change liver transplant distribution from Donor Service Areas (DSAs) to a…